与安慰剂相比,万络和鲁米昔布高于其两倍的心脏病风险。
Compared to placebos, Vioxx and Prexige were associated with twice the risk of heart attack.
另外,研究人员观察了伴随不在美国销售的其他三种药物的心血管相对风险,其中有万络、托昔布和鲁米昔布。
In addition, researchers looked at the relative cardiovascular risks associated with three other drugs not sold in the U. S., including Vioxx, Arcoxia, and Prexige.
应用推荐